3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
22
Neoplasms
20
Lung Neoplasms
10
Colorectal Neoplasms
8
Uterine Cervical Neoplasms
6
Papillomavirus Infections
5
Head and Neck Neoplasms
5
Fatigue
5
Multiple Myeloma
4
Lymphoma
4
Hematologic Neoplasms
4
Urinary Bladder Neoplasms
3
Skin Neoplasms
3
Prostatic Neoplasms
3
Melanoma
3
Hematopoietic and Lymphoid System Neoplasm
3
Gastrointestinal Neoplasms
3
Sleep Wake Disorders
2
Skin Cancer Prevention
2
Obesity
2
Neoplasm Metastasis
2
Motor Activity
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Hematopoietic and Lymphatic System Neoplasm
2
Diabetes Mellitus
2
Depression
2
Caregiver
2
Cancer Survivor
2
Interventions
padeliporfin
4
motexafin gadolinium
2
Sunitinib
2
Radiotherapy
2
Paclitaxel
2
Genetic Testing
2
Carboplatin
2
vinflunine
1
temsirolimus
1
sipuleucel-T
1
niraparib
1
luprolide acetate gel depot
1
apalutamide
1
Tinzaparin
1
Therapeutics
1
Taste
1
Surveys and Questionnaires
1
Specimen Handling
1
Sildenafil Citrate
1
Remote Patient Monitoring
1
Radiation Dose Hypofractionation
1
Pemetrexed
1
Ocoxin
1
Neoadjuvant Therapy
1
Leuprolide
1
Immunotherapy
1
Imatinib Mesylate
1
Imagery, Psychotherapy
1
Genetic Counseling
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Urogenital Neoplasms
×
Educational Status
×
Clear all
NCT04679675
2023-09-18
STEP
Kaiser Permanente
Phase NA
Completed
32,771 enrolled
11 charts